Rohto Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 1.07% vs 2.07% in Mar 2026",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 81.83% vs -42.51% in Mar 2026",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "91,624.00",
          "val2": "90,654.00",
          "chgp": "1.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "18,159.00",
          "val2": "12,140.00",
          "chgp": "49.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "320.00",
          "val2": "371.00",
          "chgp": "-13.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-93.00",
          "val2": "-196.00",
          "chgp": "52.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "11,048.00",
          "val2": "6,076.00",
          "chgp": "81.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "149.10%",
          "val2": "82.40%",
          "chgp": "6.67%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 11.37% vs 13.95% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 11.20% vs -1.41% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "343,725.00",
          "val2": "308,625.00",
          "chgp": "11.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "58,083.00",
          "val2": "51,608.00",
          "chgp": "12.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1,284.00",
          "val2": "949.00",
          "chgp": "35.30%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1,287.00",
          "val2": "-2,068.00",
          "chgp": "37.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "34,417.00",
          "val2": "30,951.00",
          "chgp": "11.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "118.40%",
          "val2": "124.60%",
          "chgp": "-0.62%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ

Jun'26

Mar'26

Change(%)

Net Sales

91,624.00

90,654.00

1.07%

Operating Profit (PBDIT) excl Other Income

18,159.00

12,140.00

49.58%

Interest

320.00

371.00

-13.75%

Exceptional Items

-93.00

-196.00

52.55%

Consolidate Net Profit

11,048.00

6,076.00

81.83%

Operating Profit Margin (Excl OI)

149.10%

82.40%

6.67%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2026 is 1.07% vs 2.07% in Mar 2026

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2026 is 81.83% vs -42.51% in Mar 2026

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

343,725.00

308,625.00

11.37%

Operating Profit (PBDIT) excl Other Income

58,083.00

51,608.00

12.55%

Interest

1,284.00

949.00

35.30%

Exceptional Items

-1,287.00

-2,068.00

37.77%

Consolidate Net Profit

34,417.00

30,951.00

11.20%

Operating Profit Margin (Excl OI)

118.40%

124.60%

-0.62%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2026 is 11.37% vs 13.95% in Mar 2025

Consolidated Net Profit

YoY Growth in year ended Mar 2026 is 11.20% vs -1.41% in Mar 2025

All Annual Results